Guggenheim Capital LLC Trillium Therapeutics Inc. Transaction History

Guggenheim Capital LLC

  • $12.3 Billion
  • Q2 2025

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
N/A
-72,367 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
N/A
18,715 Added 34.88%
72,367 $1.27 Million
Q2 2021

Aug 13, 2021
BUY
N/A
2,455 Added 4.8%
53,652 $520,000
Q1 2021

May 13, 2021
BUY
N/A
24,415 Added 91.16%
51,197 $550,000
Q4 2020

Feb 16, 2021
BUY
N/A
26,782 New
26,782 $394,000

About Trillium Therapeutics Inc.

TRIL Quotes by TradingView
  • Ticker TRIL
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,995,000
  • Market Cap $1.94B
More about TRIL
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email